A kidney cancer vaccine candidate has shown great promise in an early Phase I trial published this week.
Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
Related Posts
Chris McQuarrie is already moving on to his next collaboration…
One of the best features of Apple’s wireless earbuds—their sleek…